Search

Your search keyword '"Margueritte, Geneviève"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Margueritte, Geneviève" Remove constraint Author: "Margueritte, Geneviève"
40 results on '"Margueritte, Geneviève"'

Search Results

1. Decreased Nonrelapse Mortality after Unrelated Cord Blood Transplantation for Acute Myeloid Leukemia Using Reduced-Intensity Conditioning: A Prospective Phase II Multicenter Trial

2. Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE)

4. Familial history of cancer and childhood acute leukemia: a French population-based case-control study

5. Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

6. Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react

7. Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol

8. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

9. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

10. Childhood hodgkinʼs lymphoma, non-hodgkinʼs lymphoma and factors related to the immune system: The escale study (SFCE)

13. Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE†)

14. O.094 MINIMAL RESIDUAL DISEASE (MRD) IN CHILDHOOD STANDARD-RISK B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (SR-BCP-ALL) AT THE END OF INDUCTION (EOI) AFTER A THREE OR FOUR-DRUG INDUCTION

16. Follow‐up of post‐transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react

17. Inherited long QT syndrome revealed by drug to drug interaction

18. Aminophylline for the treatment of neurotoxicity related to high-dose methotrexate

19. Publié dans Hématologie, vol. 17, no 3, mai-juin, 2011

20. French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

21. Daunorubicin or Not During the Induction Treatment of Childhood Standard-Risk B-Cell Precursor Acute Lymphoblastic Leukemia (SR-BCP-ALL): The Randomized Fralle 2000-A Protocol

22. Impact of NK Cell Reconstitution and Recipient HLA-C Typing on Clinical Outcome after Reduced Intensity Cord Blood Transplant: Results of a Prospective Phase II Multicentric Trial on Behalf of Societe Francaise De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord

23. At the core of professional practice in hematology

25. Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in Induction Therapy of Childhood ALL Are Equally Effective: Results of the 2nd Interim Analysis of EORTC Trial 58951

26. Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

27. Prognostic Significance of Central Nervous System (CNS) Status of Children with Acute Lymphoblastic Leukemia (ALL) Treated without Cranial Irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58951

28. Improved Prognosis of Children and Adolescents with Acute Lymphoblastic Leukemia (ALL) and Very-High Minimal Residual Disease (MRD) and the End of Induction therapy (EOI)? Preliminary Results of the FRALLE 2000 Protocol

29. High-Sensitivity Monitoring of Hematopoietic Chimerism after Double Umbilical Cord Blood Transplantation by Real-Time Quantitative Polymerase Chain Reaction.

30. Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE)

33. Reconstitution Of NK Cells After Reduced Intensity Conditioned Unrelated Cord Blood Transplantation In Patients With Acute Myeloid Leukemia: Analysis Of a Prospective Phase II Multicentric Trial On Behalf Of Societe Française De Greffe De Moelle Osseuse Et Therapie Cellulaire (SFGM-TC) and Eurocord

35. Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

36. Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

38. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

40. High-Dose Methotrexate-Induced Bullous Variant of Acral Erythema

Catalog

Books, media, physical & digital resources